Become A Featured Company

Abattis Enters Cannabinoid-Infused Beverages Market in a Big Way

Ryan Allway

January 23rd, 2018

Exclusive, News, Top News

The Canadian cannabis industry is expected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of recreational marijuana nationwide. While cannabis flower has garnered the most attention, cannabis-infused products are quickly becoming the most promising area for investment and development. These products are expected to be legalized by the federal government over the short-term.

Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) plans to introduce cannabinoid-infused beer through a new partnership with a premier Vancouver-based craft brewery.

Cannabinoid-infused Beer

Constellation Brands Inc.’s (NYSE: STZ) acquisition of a 9.9 percent stake in Canopy Growth Corp. (TSX: WEED) for C$245 million (US$191 million) underscores this interest. Constellation Brands is one of the largest beverage companies in the world with $7.3 billion in fiscal 2017 revenue – as well as the owner of iconic brands like Corona beer – and CEO Rob Sands hopes to eventually release cannabis infused beverages. Abattis may well beat them to the punch.

There has been a longstanding interest in cannabinoid-infused beer, wine, and spirits. In fact, hops and cannabis are members of the same genus and have a similar molecular structure. There are several brands popping up in Colorado and other states that have recently passed laws legalizing cannabis products.

In addition to beer, wine, and spirits, many companies have already brought cannabis-infused products into the beverage industry. Catapult Coffee Pods provide cannabis-infused coffees; Legal by Mirth Provisions provides cannabis-infused cold tonics; Lift by Dixie Elixirs provides cannabis-infused energy drinks; and, Canna Cola launched a cannabis infused soda pop – and there are countless other examples across product categories.

Abattis Enters the Market

Abattis Bioceuticals recently announced a partnership with Faculty Brewing Co, a Vancouver-based craft brewery, to develop a hemp-infused, cannabinoid-rich, THC-free craft beer that will compete in this exciting new market. In addition, the move could create a proof-of-concept that the company could replicate with other brewers as well as across many other beverage markets, including coffees, sodas, and energy drinks.

“Our exciting partnership with Faculty Brewing positions us as one of the first Canadian companies to secure an agreement for research and development, analytical and regulatory services relating to a hemp- and cannabis-infused beverage,” said Rob Abenante, President and CEO of Abattis. “By aiming to develop a line of functional beers, each based on a different type of hemp extract, we hope to have a product that is compliant and market-ready.”

The company contracted Northern Vine Labs to provide cannabinoid-rich, THC-free, hemp extract and to carry out the research, development, and analytical testing. As a licensed dealer, Northern Vine Labs has the ability to import/export cannabis and cannabis oils, as well as to conduct certain activities related to developing cannabis products. The lab is co-owned by Abattis and Emerald Health Therapeutics Ltd. (TSX-V: EMH) (OTC: EMHTF).

Looking Ahead

Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) represents a compelling investment opportunity in the legal cannabis industry. With its partnership with Faculty Brewing, the company is entering an exciting new industry that has already seen tremendous interest among large multinational beverage companies. Success in creating new products could open the door to possibilities in other beverage related niche markets.

For more information, visit the company’s website at www.abattis.com.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading